Vaccination

France's Sanofi to invest 2 billion euros in mRNA vaccines

French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.

Diseases, Conditions, Syndromes

How mRNA vaccines help fight cancer tumors

Thanks to researchers in different fields who put in nearly two decades of past work on mRNA vaccine technology, people around the world are being immunized today from COVID-19—and hopefully leading us out of this pandemic. ...

Diseases, Conditions, Syndromes

mRNA vaccines effective for preventing symptomatic COVID-19

For health care personnel (HCP), the vaccine effectiveness (VE) of authorized mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) against symptomatic COVID-19 illness is 82 and 94 percent for a single dose and for two doses, ...

page 22 from 33